Integrative Omics Analysis Reveals the Potential Value of CEACAM6 in Pan‐Gastrointestinal Cancers
Immunity, Inflammation and Disease · 2026-02 · 14 (2)
DOI: 10.1002/iid3.70327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 04.02.2026. Verfasst von Liying Jin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Xianju People's Hospital, Taizhou, China. Hauptthemen laut MEDLINE: Cell Adhesion Molecules, Antigens, CD, Gastrointestinal Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Science and Technology Project of Zhejiang Province, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Objective
Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) is known as a cell adhesion receptor which could regulate proliferation and other signaling in cancer. The role of CEACAM6 in pan‐gastrointestinal cancers remains largely uncharacterized. This study employed multi‐omics bioinformatics to investigate the expression distribution, prognostic value, and immune function of CEACAM6 in these malignancies.
Methods
Utilizing multi‐omics data from The Cancer Genome Atlas (TCGA), cBioPortal, GDSC2, TIMER2.0, and TISCH databases, we assessed the CEACAM6 expression and prognostic value across pan‐gastrointestinal cancers. Additionally, the potential role of CEACAM6 in the tumor immune microenvironment was explored using multi‐omics data, including spatial transcriptomics data.
Results
Based on TCGA data, CEACAM6 was found to be overexpressed in pan‐gastrointestinal cancers. The CEACAM6 somatic copy number alterations, DNA methylation and mutation sites were identified as potential contributors to abnormal CEACAM6 expression. The CEACAM6 expression was significantly negatively associated with the abundance of CD4 + Th1 cells across pan‐gastrointestinal cancers. Furthermore, spatial transcriptomics data revealed that CEACAM6 expression was significant positively associated with malignant cells, while there was a negative correlation was observed with between CEACAM6 expression and plasma cells.
Conclusion
CEACAM6 exhibits high diagnostic accuracy and tumor‐specific overexpression in pan‐gastrointestinal cancers. CEACAM6 could promote angiogenesis/metastasis and suppress anti‐tumor immunity. Spatially localized in tumors with immune cell exclusion, CEACAM6 correlates with poor survival and immune‐excluded subtypes, positioning it as a therapeutic target in precision immunotherapy for pan‐gastrointestinal cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Xianju People's Hospital, Taizhou, China.
- Department of Radiation Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
- Department of Neurology, Yueyang People's Hospital, Yueyang, China.
- Department of Medical Oncology, Zhejiang Provincial People's Hospital, Hangzhou, China.
- Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
ORCID-Profile: Peng Zhang
Förderung
- Medical Science and Technology Project of Zhejiang Province
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Jin, L., Tao, C., Pan, Z., & Zhang, P. (2026). Integrative Omics Analysis Reveals the Potential Value of CEACAM6 in Pan‐Gastrointestinal Cancers. Immunity, Inflammation and Disease, 14(2). https://doi.org/10.1002/iid3.70327
Vancouver
Jin L, Tao C, Pan Z, Zhang P. Integrative Omics Analysis Reveals the Potential Value of CEACAM6 in Pan‐Gastrointestinal Cancers. Immunity, Inflammation and Disease. 2026;14(2). doi:10.1002/iid3.70327
BibTeX
@article{Jin2026,
author = {Jin, Liying and Tao, Changjuan and Pan, Zhiyong and Zhang, Peng},
title = {Integrative Omics Analysis Reveals the Potential Value of CEACAM6 in Pan‐Gastrointestinal Cancers},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {2},
doi = {10.1002/iid3.70327}
}
EUVIMED